Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence

Heidi Hopkins, Ambrose Talisuna, Christopher Jm Whitty, Sarah G Staedke, Heidi Hopkins, Ambrose Talisuna, Christopher Jm Whitty, Sarah G Staedke

Abstract

Background: Home-based management of malaria (HMM) is promoted as a major strategy to improve prompt delivery of effective malaria treatment in Africa. HMM involves presumptively treating febrile children with pre-packaged antimalarial drugs distributed by members of the community. HMM has been implemented in several African countries, and artemisinin-based combination therapies (ACTs) will likely be introduced into these programmes on a wide scale.

Case presentations: The published literature was searched for studies that evaluated the health impact of community- and home-based treatment for malaria in Africa. Criteria for inclusion were: 1) the intervention consisted of antimalarial treatment administered presumptively for febrile illness; 2) the treatment was administered by local community members who had no formal education in health care; 3) measured outcomes included specific health indicators such as malaria morbidity (incidence, severity, parasite rates) and/or mortality; and 4) the study was conducted in Africa. Of 1,069 potentially relevant publications identified, only six studies, carried out over 18 years, were identified as meeting inclusion criteria. Heterogeneity of the evaluations, including variability in study design, precluded meta-analysis.

Discussion and evaluation: All trials evaluated presumptive treatment with chloroquine and were conducted in rural areas, and most were done in settings with seasonal malaria transmission. Conclusions regarding the impact of HMM on morbidity and mortality endpoints were mixed. Two studies showed no health impact, while another showed a decrease in malaria prevalence and incidence, but no impact on mortality. One study in Burkina Faso suggested that HMM decreased the proportion of severe malaria cases, while another study from the same country showed a decrease in the risk of progression to severe malaria. Of the four studies with mortality endpoints only one from Ethiopia showed a positive impact, with a reduction in the under-5 mortality rate of 40.6% (95% CI 29.2 - 50.6).

Conclusion: Currently the evidence base for HMM in Africa, particularly regarding use of ACTs, is narrow and priorities for further research are discussed. To optimize treatment and maximize health benefits, drug regimens and delivery strategies in HMM programmes may need to be tailored to local conditions. Additional research could help guide programme development, policy decision-making, and implementation.

Figures

Figure 1
Figure 1
Categorization of published articles identified by the search strategy.
Figure 2
Figure 2
Sites of published studies on the health impact of home- and community-based treatment for malaria in Africa. Two studies were conducted in Burkina Faso. The map, adapted from MARA: Mapping Malaria Risk in Africa [69], shows seasonality of malaria transmission in months per year, as in the key.

References

    1. Breman JG. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg. 2001;64:1–11.
    1. Breman JG, Alilio MS, Mills A. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg. 2004;71:1–15.
    1. Snow RW, Craig M, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ. 1999;77:624–640.
    1. Reyburn H, Mbatia R, Drakeley C, Bruce J, Carneiro I, Olomi R, Cox J, Nkya WM, Lemnge M, Greenwood BM, Riley EM. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA. 2005;293:1461–1470. doi: 10.1001/jama.293.12.1461.
    1. Marsh K, Snow RW. Malaria transmission and morbidity. Parassitologia. 1999;41:241–246.
    1. WHO/RBM . Global strategic plan 2005-2015. World Health Organization / Roll Back Malaria Partnership; 2005.
    1. Kager PA. Malaria control: constraints and opportunities. Trop Med Int Health. 2002;7:1042–1046. doi: 10.1046/j.1365-3156.2002.00981.x.
    1. Moerman F, Lengeler C, Chimumbwa J, Talisuna A, Erhart A, Coosemans M, D'Alessandro U. The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis. 2003;3:99–102. doi: 10.1016/S1473-3099(03)00518-8.
    1. Ruebush TK, Kern MK, Campbell CC, Oloo AJ. Self-treatment of malaria in a rural area of western Kenya. Bull World Health Organ. 1995;73:229–236.
    1. Sauerborn R, Adams A, Hien M. Household strategies to cope with the economic costs of illness. Soc Sci Med. 1996;43:291–301. doi: 10.1016/0277-9536(95)00375-4.
    1. Foster S. Treatment of malaria outside the formal health services. J Trop Med Hyg. 1995;98:29–34.
    1. Wiseman V, Kim M, Mutabingwa TK, Whitty CJ. Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med. 2006;3:e373. doi: 10.1371/journal.pmed.0030373.
    1. McCombie SC. Treatment seeking for malaria: a review of recent research. Soc Sci Med. 1996;43:933–945. doi: 10.1016/0277-9536(95)00446-7.
    1. WHO . Scaling up home-based management of malaria: from research to implementation. Geneva, World Health Organization; 2004.
    1. WHO . The Roll Back Malaria strategy for improving access to treatment through home management for malaria. , World Health Organization; 2005.
    1. Yeboah-Antwi K, Gyapong JO, Asare IK, Barnish G, Evans DB, Adjei S. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bull World Health Organ. 2001;79:394–399.
    1. Ansah EK, Gyapong JO, Agyepong IA, Evans DB. Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health. 2001;6:496–504. doi: 10.1046/j.1365-3156.2001.00740.x.
    1. Kallander K, Tomson G, Nsungwa-Sabiiti J, Senyonjo Y, Pariyo G, Peterson S. Community referral in home management of malaria in western Uganda: a case series study. BMC Int Health Hum Rights. 2006;6:2. doi: 10.1186/1472-698X-6-2.
    1. Duong S, Lim P, Fandeur T, Tsuyuoka R, Wongsrichanalai C. Importance of protection of antimalarial combination therapies. Lancet. 2004;364:1754–1755. doi: 10.1016/S0140-6736(04)17391-1.
    1. Talisuna AO, Bloland P, D'Alessandro U. History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev. 2004;17:235–254. doi: 10.1128/CMR.17.1.235-254.2004.
    1. Snow RW, Eckert E, Teklehaimanot A. Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa. Trends Parasitol. 2003;19:363–369. doi: 10.1016/S1471-4922(03)00168-5.
    1. WHO Global AMDP database - AFRO
    1. D'Alessandro U, Talisuna A, Boelaert M. Editorial: Should artemisinin-based combination treatment be used in the home-based management of malaria? Trop Med Int Health. 2005;10:1–2. doi: 10.1111/j.1365-3156.2004.01375.x.
    1. Pagnoni F, Kengeya-Kayondo J, Ridley R, Were W, Nafo-Traore F, Namboze J, Sirima S. Artemisinin-based combination treatment in home-based management of malaria. Trop Med Int Health. 2005;10:621–622. doi: 10.1111/j.1365-3156.2005.01413.x.
    1. Magnussen P, Ndawi B, Sheshe AK, Byskov J, Mbwana K. Malaria diagnosis and treatment administered by teachers in primary schools in Tanzania. Trop Med Int Health. 2001;6:273–279. doi: 10.1046/j.1365-3156.2001.00720.x.
    1. Kolaczinski JH, Ojok N, Opwonya J, Meek S, Collins A. Adherence of community caretakers of children to pre-packaged antimalarial medicines (HOMAPAK) among internally displaced people in Gulu district, Uganda. Malar J. 2006;5:40. doi: 10.1186/1475-2875-5-40.
    1. Menon A, Joof D, Rowan KM, Greenwood BM. Maternal administration of chloroquine: an unexplored aspect of malaria control. J Trop Med Hyg. 1988;91:49–54.
    1. Winch PJ, Bagayoko A, Diawara A, Kane M, Thiero F, Gilroy K, Daou Z, Berthe Z, Swedberg E. Increases in correct administration of chloroquine in the home and referral of sick children to health facilities through a community-based intervention in Bougouni District, Mali. Trans R Soc Trop Med Hyg. 2003;97:481–490. doi: 10.1016/S0035-9203(03)80001-9.
    1. Chinbuah AM, Gyapong JO, Pagnoni F, Wellington EK, Gyapong M. Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Trop Med Int Health. 2006;11:1003–1016. doi: 10.1111/j.1365-3156.2006.01654.x.
    1. Malimbo M, Mugisha E, Kato F, Karamagi C, Talisuna AO. Caregivers' perceived treatment failure in home-based management of fever among Ugandan children aged less than five years. Malar J. 2006;5:124. doi: 10.1186/1475-2875-5-124.
    1. Nsabagasani X, Nsungwa-Sabiiti J, Kallander K, Peterson S, Pariyo G, Tomson G. Home based management of fever in rural Uganda: community perceptions and provider opinions. Malar J. 2007;6:11. doi: 10.1186/1475-2875-6-11.
    1. Onwujekwe O, Dike N, Ojukwu J, Uzochukwu B, Ezumah N, Shu E, Okonkwo P. Consumers stated and revealed preferences for community health workers and other strategies for the provision of timely and appropriate treatment of malaria in southeast Nigeria. Malar J. 2006;5:117. doi: 10.1186/1475-2875-5-117.
    1. Haegeman F, Wyffels A, Alzouma G. Malaria control by village health workers in the province of Dosso, Niger. Part. 2. Epidemiological impact. Ann Soc Belg Med Trop. 1985;65:145–151.
    1. Moir JS, Tulloch JL, Vrbova H, Jolley DJ, Heywood PF, Alpers MP. The role of voluntary village aides in the control of malaria by presumptive treatment of fever. 2. Impact on village health. P N G Med J. 1985;28:267–278.
    1. Spencer HC, Kaseje DC, Collins WE, Shehata MG, Turner A, Stanfill PS, Huong AY, Roberts JM, Villinski M, Koech DK. Community-based malaria control in Saradidi, Kenya: description of the programme and impact on parasitaemia rates and antimalarial antibodies. Ann Trop Med Parasitol. 1987;81 Suppl 1:13–23.
    1. Spencer HC, Kaseje DC, Mosley WH, Sempebwa EK, Huong AY, Roberts JM. Impact on mortality and fertility of a community-based malaria control programme in Saradidi, Kenya. Ann Trop Med Parasitol. 1987;81 Suppl 1:36–45.
    1. Greenwood BM, Greenwood AM, Bradley AK, Snow RW, Byass P, Hayes RJ, N'Jie AB. Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. Lancet. 1988;1:1121–1127. doi: 10.1016/S0140-6736(88)91949-6.
    1. Menon A, Snow RW, Byass P, Greenwood BM, Hayes RJ, N'Jie AB. Sustained protection against mortality and morbidity from malaria in rural Gambian children by chemoprophylaxis given by village health workers. Trans R Soc Trop Med Hyg. 1990;84:768–772. doi: 10.1016/0035-9203(90)90071-L.
    1. Delacollette C, Van der Stuyft P, Molima K. Using community health workers for malaria control: experience in Zaire. Bull World Health Organ. 1996;74:423–430.
    1. Pagnoni F, Convelbo N, Tiendrebeogo J, Cousens S, Esposito F. A community-based programme to provide prompt and adequate treatment of presumptive malaria in children. Trans R Soc Trop Med Hyg. 1997;91:512–517. doi: 10.1016/S0035-9203(97)90006-7.
    1. Kidane G, Morrow RH. Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial. Lancet. 2000;356:550–555. doi: 10.1016/S0140-6736(00)02580-0.
    1. Sirima SB, Konate A, Tiono AB, Convelbo N, Cousens S, Pagnoni F. Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health. 2003;8:133–139. doi: 10.1046/j.1365-3156.2003.00997.x.
    1. Kaseje DC, Spencer HC. The Saradidi, Kenya, rural health development programme. Ann Trop Med Parasitol. 1987;81 Suppl 1:1–12.
    1. Spencer HC, Kaseje DC, Sempebwa EK, Huong AY, Roberts JM, Mosley WH. The Saradidi, Kenya, rural health development programme: retrospective demographic analysis. Ann Trop Med Parasitol. 1987;81 Suppl 1:24–35.
    1. WHO/TDR . Lessons learned in home management of malaria: Implementation research in four African countries. , World Health Organization / Special Programme for Research and Training in Tropical Diseases (TDR); 2007.
    1. Onwujekwe O, Uzochukwu B, Ojukwu J, Dike N, Shu E. Feasibility of a community health worker strategy for providing near and appropriate treatment of malaria in southeast Nigeria: an analysis of activities, costs and outcomes. Acta Trop. 2007;101:95–105. doi: 10.1016/j.actatropica.2006.07.013.
    1. Goodman CA, Coleman PG, Mills AJ. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet. 1999;354:378–385. doi: 10.1016/S0140-6736(99)02141-8.
    1. Malik EM, Mohamed TA, Elmardi KA, Mowien RM, Elhassan AH, Elamin SB, Mannan AA, Ahmed ES. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. Malar J. 2006;5:65. doi: 10.1186/1475-2875-5-65.
    1. Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop. 2005;95:305–315. doi: 10.1016/j.actatropica.2005.06.009.
    1. Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. Malar J. 2007;6:31. doi: 10.1186/1475-2875-6-31.
    1. Payne D. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? Parasitol Today. 1988;4:112–115. doi: 10.1016/0169-4758(88)90042-7.
    1. Vallely A, Vallely L, Changalucha J, Greenwood B, Chandramohan D. Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? Malar J. 2007;6:16. doi: 10.1186/1475-2875-6-16.
    1. O'Meara WP, Smith DL, McKenzie FE. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med. 2006;3:e141. doi: 10.1371/journal.pmed.0030141.
    1. Laxminarayan R, Over M, Smith DL. Will a global subsidy of new antimalarials delay the emergence of resistance and save lives? Health Aff (Millwood) 2006;25:325–336. doi: 10.1377/hlthaff.25.2.325.
    1. White NJ, Olliaro PL. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol Today. 1996;12:399–401. doi: 10.1016/0169-4758(96)10055-7.
    1. Price RN, Nosten F. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resist Updat. 2001;4:187–196. doi: 10.1054/drup.2001.0195.
    1. Katabarwa M, Mutabazi D, Richards FO., Jr. Monetary incentives and community-directed health programmes in some less-developed countries. Lancet. 1999;354:1909. doi: 10.1016/S0140-6736(05)76878-1.
    1. Donnelly MJ, McCall PJ, Lengeler C, Bates I, D'Alessandro U, Barnish G, Konradsen F, Klinkenberg E, Townson H, Trape JF, Hastings IM, Mutero C. Malaria and urbanization in sub-Saharan Africa. Malar J. 2005;4:12. doi: 10.1186/1475-2875-4-12.
    1. Keiser J, Utzinger J, Caldas de Castro M, Smith TA, Tanner M, Singer BH. Urbanization in sub-saharan Africa and implication for malaria control. Am J Trop Med Hyg. 2004;71:118–127.
    1. TDR . 16th Programme Report. , Special Programme for Research and Training in Tropical Diseases (TDR); 2003. Tropical disease research: progress 2001-2002, New and improved policies and control strategies; pp. 53–63.
    1. Jonkman A, Chibwe RA, Khoromana CO, Liabunya UL, Chaponda ME, Kandiero GE, Molyneux ME, Taylor TE. Cost-saving through microscopy-based versus presumptive diagnosis of malaria in adult outpatients in Malawi. Bull World Health Organ. 1995;73:223–227.
    1. Olivar M, Develoux M, Chegou Abari A, Loutan L. Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel. Trans R Soc Trop Med Hyg. 1991;85:729–730. doi: 10.1016/0035-9203(91)90432-X.
    1. Chandramohan D, Jaffar S, Greenwood B. Use of clinical algorithms for diagnosing malaria. Trop Med Int Health. 2002;7:45–52. doi: 10.1046/j.1365-3156.2002.00827.x.
    1. Sowunmi A, Akindele JA. Presumptive diagnosis of malaria in infants in an endemic area. Trans R Soc Trop Med Hyg. 1993;87:422. doi: 10.1016/0035-9203(93)90022-I.
    1. Premji Z, Minjas JN, Shiff CJ. Laboratory diagnosis of malaria by village health workers using the rapid manual ParaSight-F test. Trans R Soc Trop Med Hyg. 1994;88:418. doi: 10.1016/0035-9203(94)90409-X.
    1. Bojang KA. The diagnosis of Plasmodium falciparum infection in Gambian children, by field staff using the rapid, manual, ParaSight-F test. Ann Trop Med Parasitol. 1999;93:685–687. doi: 10.1080/00034989957925.
    1. Talisuna AO, Meya DN. Diagnosis and treatment of malaria. BMJ. 2007;334:375–376. doi: 10.1136/.
    1. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, Whitty CJ. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ. 2007;334:403. doi: 10.1136/.
    1. MARA MARA: Mapping Malaria Risk in Africa

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe